Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRETE: Enoxaparin for CVC-associated Thrombosis in Children
NCT03003390Phase 2Terminated
- Sponsor
- Yale University
- Start
- Apr 2017
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of enoxaparin in deep vein thrombosis (DVT), sponsored by Yale University. Started Apr 2017; status: terminated.
02
Drugs
enoxaparin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on NCT03003390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03003390.